Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Binimetinib and Belinostat in Metastatic Uveal Melanoma
NCT05170334Phase 2Active, not recruiting
- Sponsor
- Moffitt Cancer Center
- Start
- Dec 2021
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of binimetinib, belinostat in Uveal melanoma (UM), sponsored by Moffitt Cancer Center. Started Dec 2021; status: active, not recruiting.
02
Drugs
binimetinibbelinostat
03
Conditions
Uveal melanoma (UM)
Beyond the preview
Go deeper on NCT05170334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05170334.